Web developed by Josh Bolinger website design

The Global Leader in Preclinical Ophthalmic Research


Proprietary MiDROPS™ technology is also available to formulate small lipohilic molecules for topical instillation (eyedrop).  This patented technology platform can deliver test agents to both the anterior and posterior segments of the eye.



EyeCRO provides numerous in-vivo research models to enable directed and meaningful preclinical drug discovery and development programs. EyeCRO also has extensive experience in various routes of administration and can customize studies depending on your needs. One of the main advantages in working with EyeCRO is our ability to be flexible.

Once-daily MiDROPS™ are superior to other Cyclosporine drops dosed 2x/day and provide faster therapeutic benefit to patients

"Ophthalmic distribution studies indicate significantly increased drug concentration with … Read More

EyeCRO and MPI Research Partner to Develop New Preclinical Models of Ophthalmic Disease

Oklahoma City, OK; Ann Arbor, MI; and Mattawan, MI (PRWEB) May 01, 2017 EyeCRO and MPI Research, … Read More

Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy

"Diabetic retinopathy is a leading cause of vision loss. Previous studies have shown signaling … Read More

More News

Wednesday, December 12th, 2018 at 9:53am
@KeithWWard Rafal is too hairy....except for the top of his head! hmmm! 🤔
Wednesday, December 12th, 2018 at 8:51am
Our principal scientist couldn't be left out of the fun! https://t.co/OOA25EUQAX EyeCRO photo
Wednesday, December 12th, 2018 at 8:50am
If you have ANY involvement in ophthalmic drug/device development, READ THIS! Incredibly comprehensive and detailed assessment of what's been happening in #ophthalmology this year and what to expect going forward. Thanks @OISTWEETS and Dr. Cunningham for providing this for free! https://t.co/JCT9uv180w
EyeCRO photo
Ophthalmology Summit @OISTWEETS
What a year we've seen in #ophthalmology! And no one sees things quite like OIS Co-Chair Emmett T. Cunningham Jr., MD, PhD, MPH. Download the EXPANDED 2018 Ophthalmology Year in Review. https://t.co/aYmDNmL62i https://t.co/7gA3d3PHlq
Preclinical Ophthalmic Contract Research